The drugmaker is still dealing with the fallout over its HPV vaccine Gardasil in China, where a drop in demand forced it to halt shipments and rescind its previous forecast of $11 billion in ...

In its rush to market its human papillomavirus vaccine, Merck forgot to make a strong and compelling case for compulsory immunization. Merck's human papillomavirus (HPV) vaccine Gardasil should ...

The drugmaker plans to temporarily pause shipments of its Gardasil vaccine to China at least through the middle of the year. Chairman and CEO Robert Davis told analysts the pause will help pare ...